Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
The global Closed-loop Automated Insulin Delivery (AID) System market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the 鈥淐losed-loop Automated Insulin Delivery (AID) System Industry Forecast鈥� looks at past sales and reviews total world Closed-loop Automated Insulin Delivery (AID) System sales in 2023, providing a comprehensive analysis by region and market sector of projected Closed-loop Automated Insulin Delivery (AID) System sales for 2024 through 2030. With Closed-loop Automated Insulin Delivery (AID) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Closed-loop Automated Insulin Delivery (AID) System industry.
This Insight Report provides a comprehensive analysis of the global Closed-loop Automated Insulin Delivery (AID) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Closed-loop Automated Insulin Delivery (AID) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Closed-loop Automated Insulin Delivery (AID) System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Closed-loop Automated Insulin Delivery (AID) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Closed-loop Automated Insulin Delivery (AID) System.
United States market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Closed-loop Automated Insulin Delivery (AID) System players cover Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Closed-loop Automated Insulin Delivery (AID) System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Hybrid Closed Loop Systems
DIY Closed Loop Systems
Segmentation by Application:
Children with Type 1 Diabetes
Adults with Type 1 Diabetes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd.
Medtrum
Key Questions Addressed in this Report
What is the 10-year outlook for the global Closed-loop Automated Insulin Delivery (AID) System market?
What factors are driving Closed-loop Automated Insulin Delivery (AID) System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Closed-loop Automated Insulin Delivery (AID) System market opportunities vary by end market size?
How does Closed-loop Automated Insulin Delivery (AID) System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Closed-loop Automated Insulin Delivery (AID) System by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Closed-loop Automated Insulin Delivery (AID) System by Country/Region, 2019, 2023 & 2030
2.2 Closed-loop Automated Insulin Delivery (AID) System Segment by Type
2.2.1 Hybrid Closed Loop Systems
2.2.2 DIY Closed Loop Systems
2.3 Closed-loop Automated Insulin Delivery (AID) System Sales by Type
2.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2024)
2.3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue and Market Share by Type (2019-2024)
2.3.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Type (2019-2024)
2.4 Closed-loop Automated Insulin Delivery (AID) System Segment by Application
2.4.1 Children with Type 1 Diabetes
2.4.2 Adults with Type 1 Diabetes
2.5 Closed-loop Automated Insulin Delivery (AID) System Sales by Application
2.5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sale Market Share by Application (2019-2024)
2.5.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue and Market Share by Application (2019-2024)
2.5.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Breakdown Data by Company
3.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Company (2019-2024)
3.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Company (2019-2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Company (2019-2024)
3.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Company (2019-2024)
3.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Company (2019-2024)
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Sale Price by Company
3.4 Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Closed-loop Automated Insulin Delivery (AID) System Product Location Distribution
3.4.2 Players Closed-loop Automated Insulin Delivery (AID) System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Closed-loop Automated Insulin Delivery (AID) System by Geographic Region
4.1 World Historic Closed-loop Automated Insulin Delivery (AID) System Market Size by Geographic Region (2019-2024)
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Closed-loop Automated Insulin Delivery (AID) System Market Size by Country/Region (2019-2024)
4.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Annual Sales by Country/Region (2019-2024)
4.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.4 APAC Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.5 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Growth
4.6 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Growth
5 Americas
5.1 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country
5.1.1 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
5.1.2 Americas Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
5.2 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
5.3 Americas Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region
6.1.1 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2019-2024)
6.1.2 APAC Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2019-2024)
6.2 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
6.3 APAC Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Closed-loop Automated Insulin Delivery (AID) System by Country
7.1.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
7.1.2 Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
7.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
7.3 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System by Country
8.1.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2024)
8.1.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2024)
8.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
8.3 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Closed-loop Automated Insulin Delivery (AID) System
10.3 Manufacturing Process Analysis of Closed-loop Automated Insulin Delivery (AID) System
10.4 Industry Chain Structure of Closed-loop Automated Insulin Delivery (AID) System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Closed-loop Automated Insulin Delivery (AID) System Distributors
11.3 Closed-loop Automated Insulin Delivery (AID) System Customer
12 World Forecast Review for Closed-loop Automated Insulin Delivery (AID) System by Geographic Region
12.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size Forecast by Region
12.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Region (2025-2030)
12.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Type (2025-2030)
12.7 Global Closed-loop Automated Insulin Delivery (AID) System Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Tandem Diabetes Care
13.2.1 Tandem Diabetes Care Company Information
13.2.2 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Tandem Diabetes Care Main Business Overview
13.2.5 Tandem Diabetes Care Latest Developments
13.3 Admetsys
13.3.1 Admetsys Company Information
13.3.2 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Admetsys Main Business Overview
13.3.5 Admetsys Latest Developments
13.4 Insulet
13.4.1 Insulet Company Information
13.4.2 Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Insulet Main Business Overview
13.4.5 Insulet Latest Developments
13.5 Defymed
13.5.1 Defymed Company Information
13.5.2 Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Defymed Main Business Overview
13.5.5 Defymed Latest Developments
13.6 Beta Bionics (iLet)
13.6.1 Beta Bionics (iLet) Company Information
13.6.2 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Beta Bionics (iLet) Main Business Overview
13.6.5 Beta Bionics (iLet) Latest Developments
13.7 Bigfoot Biomedical
13.7.1 Bigfoot Biomedical Company Information
13.7.2 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bigfoot Biomedical Main Business Overview
13.7.5 Bigfoot Biomedical Latest Developments
13.8 Dexcom
13.8.1 Dexcom Company Information
13.8.2 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dexcom Main Business Overview
13.8.5 Dexcom Latest Developments
13.9 MicroTech Medical (Hangzhou) Co., Ltd.
13.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
13.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Main Business Overview
13.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
13.10 Medtrum
13.10.1 Medtrum Company Information
13.10.2 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolios and Specifications
13.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Medtrum Main Business Overview
13.10.5 Medtrum Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
